Professor Richard Scolyer was part of a world-leading duo with Professor Georgina Long that changed the treatment of melanoma using immunotherapy, dramatically improving survival rates. Then in 2023, Scolyer himself was diagnosed with brain cancer — the cancer with one of the lowest survival rates — which has barely improved in more than 20 years. Scolyer has undergone experimental treatment based on the team's previous research on immunotherapy, as well as more conventional treatments. Clinical